Abigail Anne Risic

Array ( [id] => 4469859 [patent_doc_number] => 07943575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Sustained release drug formulations containing a carrier peptide' [patent_app_type] => utility [patent_app_number] => 10/506263 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6896 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943575.pdf [firstpage_image] =>[orig_patent_app_number] => 10506263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224497 [patent_doc_number] => 20040072750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Compounds and methods for the modulation of CD154' [patent_app_type] => new [patent_app_number] => 10/376425 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25295 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072750.pdf [firstpage_image] =>[orig_patent_app_number] => 10376425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180407 [patent_doc_number] => 20050124531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Biological inhibitions induced by contact inhibitory factor' [patent_app_type] => utility [patent_app_number] => 10/505715 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5598 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124531.pdf [firstpage_image] =>[orig_patent_app_number] => 10505715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163952 [patent_doc_number] => 20050085623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Bone targeting peptides' [patent_app_type] => utility [patent_app_number] => 10/503574 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6739 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085623.pdf [firstpage_image] =>[orig_patent_app_number] => 10503574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7354952 [patent_doc_number] => 20040048803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Compounds and methods for the modulation of CD154' [patent_app_type] => new [patent_app_number] => 10/368947 [patent_app_country] => US [patent_app_date] => 2003-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 23613 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048803.pdf [firstpage_image] =>[orig_patent_app_number] => 10368947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467425 [patent_doc_number] => 20040053821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Inhibitors of RGS proteins' [patent_app_type] => new [patent_app_number] => 10/365840 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13615 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053821.pdf [firstpage_image] =>[orig_patent_app_number] => 10365840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732380 [patent_doc_number] => 20060257497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Use of Tryptophan rich peptides' [patent_app_type] => utility [patent_app_number] => 10/544862 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2906 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257497.pdf [firstpage_image] =>[orig_patent_app_number] => 10544862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743585 [patent_doc_number] => 20060089310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Treatment of infections and other disorders' [patent_app_type] => utility [patent_app_number] => 10/503555 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3102 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089310.pdf [firstpage_image] =>[orig_patent_app_number] => 10503555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730655 [patent_doc_number] => 20030186845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Compositions for preventing urinary calculus' [patent_app_type] => new [patent_app_number] => 10/343760 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4632 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186845.pdf [firstpage_image] =>[orig_patent_app_number] => 10343760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701463 [patent_doc_number] => 20030224343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Kappa-PVIIA-related conotoxins as organ protectants' [patent_app_type] => new [patent_app_number] => 10/352254 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15551 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224343.pdf [firstpage_image] =>[orig_patent_app_number] => 10352254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926441 [patent_doc_number] => 20050239697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Methods and compositions for the promotion of hair growth utilizing actin binding peptides' [patent_app_type] => utility [patent_app_number] => 10/502115 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14711 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239697.pdf [firstpage_image] =>[orig_patent_app_number] => 10502115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743573 [patent_doc_number] => 20060089298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Novel substances k01-b0171 and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/508413 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5320 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089298.pdf [firstpage_image] =>[orig_patent_app_number] => 10508413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6844671 [patent_doc_number] => 20030150018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus' [patent_app_type] => new [patent_app_number] => 10/345020 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23236 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20030150018.pdf [firstpage_image] =>[orig_patent_app_number] => 10345020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6707776 [patent_doc_number] => 20030154510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus' [patent_app_type] => new [patent_app_number] => 10/342821 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23212 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20030154510.pdf [firstpage_image] =>[orig_patent_app_number] => 10342821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730700 [patent_doc_number] => 20030186890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Amphipathic linear peptides and formulations containing said peptides' [patent_app_type] => new [patent_app_number] => 10/336312 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5904 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186890.pdf [firstpage_image] =>[orig_patent_app_number] => 10336312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638771 [patent_doc_number] => 20030211979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'FAP-activated anti-tumor compounds' [patent_app_type] => new [patent_app_number] => 10/336378 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7753 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211979.pdf [firstpage_image] =>[orig_patent_app_number] => 10336378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830305 [patent_doc_number] => 20030181363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Macrocyclic peptides active against the hepatitis C virus' [patent_app_type] => new [patent_app_number] => 10/320978 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12034 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181363.pdf [firstpage_image] =>[orig_patent_app_number] => 10320978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112641 [patent_doc_number] => 07713932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Calcitonin drug-oligomer conjugates, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/166355 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713932.pdf [firstpage_image] =>[orig_patent_app_number] => 10166355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112641 [patent_doc_number] => 07713932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Calcitonin drug-oligomer conjugates, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/166355 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713932.pdf [firstpage_image] =>[orig_patent_app_number] => 10166355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112641 [patent_doc_number] => 07713932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Calcitonin drug-oligomer conjugates, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/166355 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713932.pdf [firstpage_image] =>[orig_patent_app_number] => 10166355 [rel_patent_id] =>[rel_patent_doc_number] =>)